(Q33751721)

English

Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model (English)

1 reference

Europe PubMed Central

29 July 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

author name string

Condreay LD

1

1 reference

Europe PubMed Central

29 July 2017

Jansen RW

2

1 reference

Europe PubMed Central

29 July 2017

Powdrill TF

3

1 reference

Europe PubMed Central

29 July 2017

Johnson LC

4

1 reference

Europe PubMed Central

29 July 2017

Selleseth DW

5

1 reference

Europe PubMed Central

29 July 2017

Paff MT

6

1 reference

Europe PubMed Central

29 July 2017

Daluge SM

7

1 reference

Europe PubMed Central

29 July 2017

Painter GR

8

1 reference

Europe PubMed Central

29 July 2017

Furman PA

9

1 reference

Europe PubMed Central

29 July 2017

Ellis MN

10

1 reference

Europe PubMed Central

29 July 2017

language of work or name

0 references

publication date

1 March 1994

1 reference

Europe PubMed Central

29 July 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

29 July 2017

38

1 reference

Europe PubMed Central

29 July 2017

3

1 reference

Europe PubMed Central

29 July 2017

616-619

1 reference

Europe PubMed Central

29 July 2017

The problem of antiviral therapy for chronic hepadnavirus infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284508

21 June 2018

Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284508

21 June 2018

Effects of adenine arabinoside on serum and intrahepatic replicative forms of duck hepatitis B virus in chronic infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284508

21 June 2018

Inhibition of duck hepatitis B virus replication by purine 2',3'-dideoxynucleosides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284508

21 June 2018

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284508

21 June 2018

Tumorigenicity and transcriptional modulation of c-myc and N-ras oncogenes in a human hepatoma cell line.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284508

21 June 2018

Foscarnet decreases serum and liver duck hepatitis B virus DNA in chronically infected ducks

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284508

21 June 2018

Morphologic, immunohistochemical, and ultrastructural studies of the production of hepatitis B virus in vitro.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284508

21 June 2018

Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284508

21 June 2018

Inhibition of the replication of hepatitis B virus by the carbocyclic analogue of 2'-deoxyguanosine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284508

21 June 2018

In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284508

21 June 2018

Activities of arabinosyladenine monophosphate and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against ground squirrel hepatitis virus in vivo as determined by reduction in serum virion-associated DNA polymerase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284508

21 June 2018

Comparative morphology and tumourigenicity of human hepatocellular carcinoma cell lines in athymic rats and mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284508

21 June 2018

Efficient duck hepatitis B virus production by an avian liver tumor cell line

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284508

21 June 2018

A cell culture assay for compounds which inhibit hepatitis B virus replication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284508

21 June 2018

Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284508

21 June 2018

Inhibition of intrahepatic hepatitis B virus replication by antiviral drugs in a novel transgenic mouse model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284508

21 June 2018

The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284508

21 June 2018

The mechanism of inhibition of hepatitis B virus replication by the carbocyclic analog of 2′-deoxyguanosine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284508

21 June 2018

Induction of drug metabolizing enzymes in human liver cell line Hep G2

1 reference

https://pubmed.ncbi.nlm.nih.gov/7515609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of culture medium composition on drug metabolising enzyme activities of the human liver derived Hep G2 cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/7515609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.38.3.616

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33751721&oldid=1960384898"